A Phase II Trial of LM103 in Advanced Melanoma

Clinical trial NCT07310784 · RECRUITING

Trial details

NCT number: NCT07310784
Sponsor: Suzhou BlueHorse Therapeutics Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Melanoma

Start date: 2025-12-16
Primary completion: 2027-12-31
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.